NCT00113009View on ClinicalTrials.gov

Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

148

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

July 31, 2006

Conditions

Peripheral Vascular Disease

Interventions

DRUG

VLTS-934

Trial Locations (32)

Unknown

Birmingham

Beverly Hills

Los Angeles

Mountain View

Santa Rosa

Deerfield Beach

DeLand

Jacksonville

Melbourne

Sarasota

Atlanta

Chicago

Houma

Thibodaux

Auburn

Baltimore

University of Michigan Health Systems, Ann Arbor

Flint

Las Vegas

Buffalo

New York

Asheville

Akron

Oklahoma City

Portland

Warwick

Nashville

Houston

San Antonio

Norfolk

Virgina Beach

Seattle

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Valentis

INDUSTRY

NCT00113009 - Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease | Biotech Hunter | Biotech Hunter